ClinConnect ClinConnect Logo
Search / Trial NCT06532214

Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Jul 29, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hepatectomy Liver Failure Post Hepatectomy Liver Failure

ClinConnect Summary

This clinical trial is looking at the complications that can happen after a liver surgery called hepatectomy, which is often used to treat conditions like liver cancer and other liver issues. While this surgery can be very effective, it can also lead to problems afterward, such as liver failure, infections, or bile leaks. The goal of this study is to gather more information about how often these complications occur, what might increase the risk of them happening, and how they can be prevented or treated. This information will help doctors provide better care for patients undergoing this surgery.

To be eligible for the study, participants should be between 18 and 80 years old and have had liver surgery at one of the centers involved in the trial. However, individuals who have had certain previous cancer treatments, repeated liver surgeries, or other serious health issues may not be included. Those who take part in the study can expect to share their medical information, which will help researchers gain a clearer understanding of the risks and outcomes related to liver surgery. Overall, this study aims to improve patient safety and treatment plans for future liver surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients aged 18-80 years 2.Patients who underwent liver resection surgery at the participating centers
  • Exclusion Criteria:
  • * Exclusion criteria are as follows:
  • 1. Prior cancer treatments such as transarterial chemoembolization, ablation, or targeted therapy.
  • 2. Repeat liver resection surgeries.
  • 3. Presence of other malignancies.
  • 4. Concurrent end-stage diseases including active infections, respiratory failure, decompensated heart failure, and autoimmune disease exacerbations.
  • 5. Inadequate clinical data availability in medical records.

About Nanfang Hospital, Southern Medical University

Nanfang Hospital, affiliated with Southern Medical University, is a leading medical institution in China renowned for its comprehensive clinical services and commitment to advancing healthcare through research and education. As a clinical trial sponsor, Nanfang Hospital leverages its state-of-the-art facilities and a multidisciplinary team of expert researchers to conduct innovative studies aimed at improving patient outcomes and contributing to the global medical community. The hospital's focus on ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and scientific rigor.

Locations

Guangzhou, , China

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported